VALBIOTIS announces additional positive results from phase IIA clinical study of VALEDIA

Image: VALEDIA is the first clinically validated product specifically designed to help prediabetics reduce their risk of developing type 2 diabetes. Photo: courtesy of Ewa Urban from Pixabay.